Biocon Targets ₹4,500 Crore with Equity Share Placement

Biotechnology giant, Biocon Ltd, announced setting a floor price of ₹340.2 per equity share for its qualified institutions placement aimed at raising ₹4,500 crore. This decision was authorized by its Fund Raising Committee to bolster capital through various securities, including shares and convertible instruments.

Biocon Ltd, a leading biotechnology firm, has declared a floor price of ₹340.2 per equity share for its qualified institutions placement initiative, aiming to amass ₹4,500 crore. The strategic move was sanctioned during a meeting held by its Fund Raising Committee this June.

The Board of Directors had already authorized the capital-raising effort on April 23, 2025, focusing on issuing securities to boost funds.

The approved capital raise will involve securities like shares and non-convertible debt instruments, potentially including warrants or convertible options via qualified institutions placement or rights issue, among others.

(With inputs from agencies.)